{"database": "lobbying", "table": "lobbying_activities", "rows": [[3058546, "67964581-7c92-4526-8af0-c4b6201a8b74", "Q3", "NELSON MULLINS RILEY & SCARBOROUGH", 285871, "TIDELANDS HEALTH", 2023, "third_quarter", "PHA", "Issues related to the 340B Drug Pricing Program", "SENATE", 40000, null, 0, 0, "2023-10-18T17:56:57-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3058546"], "units": {}, "query_ms": 29.675629921257496, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}